Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia

BMC Infectious Diseases

Volumn 12, Issue , 2012, Pages

  Miyashita, Naoyuki ^a   Kawai, Yasuhiro ^a   Akaike, Hiroto ^a   Ouchi, Kazunobu ^a   Hayashi, Toshikiyo ^a   Kurihara, Takeyuki ^a   Okimoto, Niro ^a,e   Maruyama, Takaya ^b   Nakahama, Chikara ^c   Yoneyama, Hirohide ^d   Kawanishi, Masayasu ^f   Kimura, Makoto ^g   Matsushima, Toshiharu ^h   Kuwabara, Masao ⁱ   Hashiguchi, Kouji ^j   Nagatomo, Yasuhiro ^k  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Nakahama Clinic   (Japan)

^d Kasaoka Daiichi Hospital   (Japan)

^e Kawasaki Hospital   (Japan)

^f Kaneda Hospital   (Japan)

^g Kimura Clinic   (Japan)

^h Kurashiki Daiichi Hospital   (Japan)

ⁱ Kenritsu Hiroshima Hospital   (Japan)

^j JAPANESE RED CROSS NAGASAKI GENBAKU HOSPITAL   (Japan)

^k UNIVERSITY OF MIYAZAKI   (Japan)

more..

Author keywords

23S rRNA; Community acquired pneumonia; Macrolide resistant; Mycoplasma pneumoniae

Indexed keywords

AZITHROMYCIN; BACTERIAL RNA; CLARITHROMYCIN; ERYTHROMYCIN; LEVOFLOXACIN; MACROLIDE; MINOCYCLINE; PRIMER RNA; RIBOSOME RNA;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; DNA SEQUENCE; HUMAN; INFANT; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PREVALENCE; PROTEIN DOMAIN; SCHOOL CHILD;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INFANT; JAPAN; MACROLIDES; MALE; MIDDLE AGED; MYCOPLASMA PNEUMONIAE; PNEUMONIA, MYCOPLASMA; POLYMERASE CHAIN REACTION; PREVALENCE; RNA, RIBOSOMAL, 23S; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 84861642075     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-12-126     Document Type: Article

References (26)

1. The committee for the Japanese Respiratory Society guidelines in management of respiratory infections The Japanese Respiratory Society guideline for the management of community-acquired pneumonia in adults. Respirology 2006, 11(Suppl 3):79-133. The committee for the Japanese Respiratory Society guidelines in management of respiratory infections.
2. National Institute of Health Infectious Disease Surveillance Center. Mycoplasma pneumoniae pneumonia 2000, National Institute of Health., http://idsc.nih.go.jp/idwr/kanja/weeklygraph/18myco.html
3. Rasmussen JN, Voldstedlund M, Andersen RL, Ellermann-Eriksen S, Jensen TG, Johansen HK, Kolmos B, Molvadgaard M, Nielsen SS, Olsen E, Schonning K, Uldum SA. Increased incidence ofMycoplasma pneumoniaeinfections detected by laboratory-based surveillance in Denmark in 2010. Euro Surveill 2010, 15:45.
4. Chalker V, Stocki T, Mentasti M, Fleming D, Harrison T. Increased incidence ofMycoplasma pneumoniaeinfection in England and Wales in 2010: multiocus variable number tandem repeat analysis typing and macrolide susceptibility. Euro Surveill 2011, 16:19.
5. Averbuch D, Hidalgo-Grass C, Moses AE, Engelhard D, Nir-Paz R. Macrolide resistance inMycoplasma pneumoniae,Israel, 2010. Emerg Infect Dis 2011, 17(6):1079-1082. 10.3201/eid1706.101558, 3358208, 21749775.
6. Polkowska A, Harjunpää A, Toikkanen S, Lappalainen M, Vuento R, Vuorinen T, Kauppinen J, Flinck H, Lyytikäinen O. Increased incidence of Mycoplasma pneumoniae infection in Finland, 2010-2011. Euro Surveill 2012, 17(5).
7. Blystad H, Ånestad G, Vestrheim DF, Madsen S, Rønning K. Increased incidence of Mycoplasma pneumoniae infection in Norway 2011. Euro Surveill 2012, 17(5).
8. Uldum SA, Bangsborg JM, Gahrn-Hansen B, Ljung R, Mølvadgaard M, Føns Petersen R, Wiid Svarrer C. Epidemic of Mycoplasma pneumoniae infection in Denmark, 2010 and 2011. Euro Surveill 2012, 17(5).
9. Chalker VJ, Stocki T, Litt D, Bermingham A, Watson J, Fleming DM, Harrison TG. Increased detection ofMycoplasma pneumoniaeinfection in children in England and Wales, October 2011 to January 2012. Euro Surveill 2012, 17:6.
10. Linde A, Ternhag A, Törner A, Claesson BE. Antibiotic prescriptions and laboratory-confirmed cases ofMycoplasma pneumoniaeduring the epidemic in Sweden in 2011. Euro Surveill 2012, 17:6.
11. Eibach D, Escuret V, Billaud G, Mekki Y, Frobert E, Bouscambert-Duchamp M, Lina B, Morfin F. Increased detection ofMycoplasma pneumoniaeinfection in children, Lyon, France, 2010 to 2011. Euro Surveill 2012, 17:8.
12. Matsuoka M, Narita M, Okazaki N, Ohya H, Yamazaki T, Ouchi K, Suzuki I, Andoh T, Kenri T, Sasaki Y, Horino A, Shintani M, Arakawa Y, Sasaki T. Characterization and molecular analysis of macrolide-resistantMycoplasma pneumoniaeclinical isolates obtained in Japan. Antimicrob Agents Chemother 2004, 48(12):4624-4630. 10.1128/AAC.48.12.4624-4630.2004, 529214, 15561835.
13. Okazaki N, Narita M, Yamada S, Izumikawa K, Umetsu M, Kenri T, Sasaki Y, Arakawa Y, Sasaki T. Characteristics of macrolide-resistantMycoplasma pneumoniaestrains isolated from patients and induced with erythromycin in vitro. Microbiol Immunol 2001, 45(8):617-620.
14. Morozumi M, Takahashi T, Ubukata K. Macrolide-resistantMycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia. J Infect Chemother 2010, 16(2):78-86. 10.1007/s10156-009-0021-4, 20094751.
15. Miyashita N, Kawai Y, Yamaguchi T, Ouchi K, Oka M, . Atypical Pathogen Study Group Macrolide-resistant Mycoplasma pneumoniae in adults with community-acquired pneumonia. Int J Antimicrob Agents 2010, 36(4):384-385. 10.1016/j.ijantimicag.2010.06.009, 20674283, Atypical Pathogen Study Group.
16. Suzuki S, Yamazaki T, Narita M, Okazaki N, Suzuki I, Andoh T, Matsuoka M, Kenri T, Arakawa Y, Sasaki T. Clinical evaluation of macrolide-resistantMycoplasma pneumoniae. Antimicrob Agents Chemother 2006, 50(2):709-712. 10.1128/AAC.50.2.709-712.2006, 1366908, 16436730.
17. Matsubara K, Morozumi M, Okada T, Matsushima T, Komiyama O, Shoji M, Ebihara T, Ubukata K, Sato Y, Akita H, Sunakawa K, Iwata S. A comparative clinical study of macrolide-sensitive and macrolide-resistantMycoplasma pneumoniaeinfections in pediatric patients. J Infect Chemother 2009, 15(6):380-383. 10.1007/s10156-009-0715-7, 20012728.
18. Kawai Y, Miyashita N, Yamaguchi T, Saitoh A, Kondoh E, Fujimoto H, Teranishi H, Inoue M, Wakabayashi T, Akaike H, Ogita S, Kawasaki K, Terada K, Kishi F, Ouchi K. Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistantMycoplasma pneumoniaepneumonia in pediatric patients. Respirology 2012, 17(2):354-362. 10.1111/j.1440-1843.2011.02102.x, 22077195.
19. Miyashita N, Kawai Y, Yamaguchi T, Ouchi K, Oka M, . Atypical Pathogen Study Group Clinical potential of diagnostic methods for the rapid diagnosis of Mycoplasma pneumoniae pneumonia in adults. Eur J Clin Microbiol Infect Dis 2011, 30(3):439-446. 10.1007/s10096-010-1107-8, 21061035, Atypical Pathogen Study Group.
20. Lucier TS, Heitzman K, Liu SK, Hu PC. Transition mutations in the 23 S rRNA of erythromycin-resistant isolates ofMycoplasma pneumoniae. Antimicrob Agents Chemother 1995, 39(12):2770-2773. 10.1128/AAC.39.12.2770, 163027, 8593017.
21. Isozumi R, Yoshimine H, Morozumi M, Ubukata K, Ariyoshi K. Adult community-acquired pneumonia caused by macrolide resistantMycoplasma pneumoniae. Respirology 2009, 14(8):1206-1208. 10.1111/j.1440-1843.2009.01619.x, 19732389.
22. Peuchant O, Menard A, Renaudin H, Morozumi M, Ubukata K, Bebear CM, Pereyre S. Increased macrolide resistance ofMycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis. J Antimicrob Chemother 2009, 64(1):52-58. 10.1093/jac/dkp160, 19429926.
23. Wolff BJ, Thacker WL, Schwartz SB, Winchell JM. Detection of macrolide resistance inMycoplasma pneumoniaeby real-time PCR and high-resolution melt analysis. Antimicrob Agents Chemother 2008, 52(10):3542-3549. 10.1128/AAC.00582-08, 2565909, 18644962.
24. Dumke R, von Baum H, Luck PC, Jacobs E. Occurrence of macrolide-resistantMycoplasma pneumoniaestrain in Germany. Clin Microbial Infect 2010, 16(6):613-616.
25. Chironna M, Sallustio A, Esposito S, Perulli M, Chinellato I, Di Bari C, Quarto M, Cardinale F. Emergence of macrolide-resistant strains during an outbreak ofMycoplasma pneumoniaeinfections in children. J Antimicrob Chemother 2011, 66(4):734-737. 10.1093/jac/dkr003, 21393214.
26. Cao B, Zhao CJ, Yin YD, Zhao F, Song SF, Bai L, Zhang JZ, Liu YM, Zhang YY, Wang H, Wang C. High prevalence of macrolide resistance inMycoplasma pneumoniaeisolates from adult and adolescent patients with respiratory tract infection in China. Clin Infect Dis 2010, 51(2):189-194. 10.1086/653535, 20540621.